BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 24859458)

  • 1. Targeting histone lysine demethylases - progress, challenges, and the future.
    Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
    Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing histone demethylase inhibitors in cells: lessons learned.
    Hatch SB; Yapp C; Montenegro RC; Savitsky P; Gamble V; Tumber A; Ruda GF; Bavetsias V; Fedorov O; Atrash B; Raynaud F; Lanigan R; Carmichael L; Tomlin K; Burke R; Westaway SM; Brown JA; Prinjha RK; Martinez ED; Oppermann U; Schofield CJ; Bountra C; Kawamura A; Blagg J; Brennan PE; Rossanese O; Müller S
    Epigenetics Chromatin; 2017; 10():9. PubMed ID: 28265301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The catalytic domains of all human KDM5 JmjC demethylases catalyse N-methyl arginine demethylation.
    Bonnici J; Oueini R; Salah E; Johansson C; Schofield CJ; Kawamura A
    FEBS Lett; 2023 Apr; 597(7):933-946. PubMed ID: 36700827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in Histone Demethylase Inhibitors.
    McAllister TE; England KS; Hopkinson RJ; Brennan PE; Kawamura A; Schofield CJ
    J Med Chem; 2016 Feb; 59(4):1308-29. PubMed ID: 26710088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the catalytic domains of multiple JmjC oxygenases using peptide substrates.
    Williams ST; Walport LJ; Hopkinson RJ; Madden SK; Chowdhury R; Schofield CJ; Kawamura A
    Epigenetics; 2014 Dec; 9(12):1596-603. PubMed ID: 25625844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM1 class flavin-dependent protein lysine demethylases.
    Burg JM; Link JE; Morgan BS; Heller FJ; Hargrove AE; McCafferty DG
    Biopolymers; 2015 Jul; 104(4):213-46. PubMed ID: 25787087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine Demethylation in Pathogenesis.
    Cao J; Yan Q
    Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scintillation proximity assay for histone demethylases.
    Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
    Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into histone lysine demethylation.
    Hou H; Yu H
    Curr Opin Struct Biol; 2010 Dec; 20(6):739-48. PubMed ID: 20970991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities.
    Arifuzzaman S; Khatun MR; Khatun R
    Biomed Pharmacother; 2020 Sep; 129():110392. PubMed ID: 32574968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-241 Has a Role in Coupling 2OG Turnover with Substrate Oxidation During KDM4-Catalysed Histone Demethylation.
    Hancock RL; Abboud MI; Smart TJ; Flashman E; Kawamura A; Schofield CJ; Hopkinson RJ
    Chembiochem; 2018 May; 19(9):917-921. PubMed ID: 29443450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study.
    Khodaverdian V; Tapadar S; MacDonald IA; Xu Y; Ho PY; Bridges A; Rajpurohit P; Sanghani BA; Fan Y; Thangaraju M; Hathaway NA; Oyelere AK
    Sci Rep; 2019 Mar; 9(1):4802. PubMed ID: 30886160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in catalysis and inhibition of the Jumonji histone demethylases.
    Sarah L; Fujimori DG
    Curr Opin Struct Biol; 2023 Dec; 83():102707. PubMed ID: 37832177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of histone lysine demethylases in prostate cancer.
    Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
    Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases.
    Walport LJ; Hopkinson RJ; Chowdhury R; Schiller R; Ge W; Kawamura A; Schofield CJ
    Nat Commun; 2016 Jun; 7():11974. PubMed ID: 27337104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
    Mao F; Shi YG
    Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of both the
    Bonnici J; Tumber A; Kawamura A; Schofield CJ
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction Mechanism of Histone Demethylation in αKG-dependent Non-Heme Iron Enzymes.
    Singh W; Quinn D; Moody TS; Huang M
    J Phys Chem B; 2019 Sep; 123(37):7801-7811. PubMed ID: 31469562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.
    Niwa H; Umehara T
    Epigenetics; 2017 May; 12(5):340-352. PubMed ID: 28277979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
    Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
    ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.